Mielóma multiplex: vizsgálatok itt: Szaúd-Arábia

2 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

  Where

  Riyadh

  Életkor

  18 év and over

  People

  440 worldwide

  Run by

  Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  See details and how to joinNCT06615479 · EU 2024-515279-37-00
• 3. fázisTaking people
  A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

  Where

  Riyadh

  Életkor

  18 év to 130 év

  People

  750 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07735637